000 01378 a2200385 4500
005 20250516072707.0
264 0 _c20120718
008 201207s 0 0 eng d
022 _a1540-8159
024 7 _a10.1111/j.1540-8159.2011.03298.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMurdock, David K
245 0 0 _aThe use of ranolazine to facilitate electrical cardioversion in cardioversion-resistant patients: a case series.
_h[electronic resource]
260 _bPacing and clinical electrophysiology : PACE
_cMar 2012
300 _a302-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetanilides
_xadministration & dosage
650 0 4 _aAged
650 0 4 _aAngina Pectoris
_xdrug therapy
650 0 4 _aAtrial Fibrillation
_xtherapy
650 0 4 _aElectric Countershock
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPiperazines
_xadministration & dosage
650 0 4 _aRanolazine
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
700 1 _aKaliebe, Jeff
700 1 _aLarrain, German
773 0 _tPacing and clinical electrophysiology : PACE
_gvol. 35
_gno. 3
_gp. 302-7
856 4 0 _uhttps://doi.org/10.1111/j.1540-8159.2011.03298.x
_zAvailable from publisher's website
999 _c21446560
_d21446560